Stay up to date with our newsletter

Get in touch!

To explore career opportunities with Sai Life Sciences, share your CV here.

Lets start the conversation!

Sign up to our newsletter

Thank you!
We will be in touch shortly.

2025.11.05

Where Nature Inspires Innovation: University of Kansas Prof. Apurba Dutta visits Sai

Dr. Apurba Dutta, Associate Professor at Department of Medicinal Chemistry, University of Kansas, USA, recently visited our Sai Life Sciences campus to deliver a masterclass on “A serine-derived second-generation chiron: Applications in the synthesis of natural and nature-like molecular scaffolds.”
During the session, he explored how simple natural molecules can serve as versatile building blocks for designing complex, biologically relevant compounds. He shared insights into nitrogen-containing molecules, which play a crucial role in many medicinally important compounds, and discussed strategies for synthesizing them efficiently with high precision.


The masterclass offered a unique opportunity for our teams to learn directly from a leading academic expert, gaining fresh perspectives on how nature inspires innovation in medicinal chemistry.
Dr. Dutta’s research focuses on the design and synthesis of bioactive natural and non-natural compounds targeting anti-infective and anti-cancer pathways. His work spans asymmetric synthesis, chiral methodologies, and medicinal chemistry applications. He received his Ph.D. from the North-Eastern Hill University, Shillong, India (1989). Subsequently he was an Alexander von Humboldt post-doctoral fellow at the University of Konstanz, Germany (1991-1992) followed by a second post-doctoral stint at the University of Kansas, USA (1993-1995).


At Sai, we value such interactions with academic leaders, as they enrich our scientific approach and strengthen our commitment to continuous learning, collaboration, and the discovery of new solutions in drug development.

Share article

More News

2026.01.28

Mabtech and Sai Life Sciences Announce Strategic Collaboration to Advance Immunology Research with EYRA Platform at Sai Boston Site

Mabtech, a global life science tools company specializing in advanced immunoassays, and Sai Life Sciences, a leading integrated Contract Research, Development, and Manufacturing Organization (CRDMO), today announced a strategic collaboration that establishes Sai’s Boston laboratory as a co-marketed US execution and demonstration hub for the Mabtech EYRA™ platform. Under this collaboration, Mabtech and Sai will […]
Read more

2026.01.12

Sai Life Sciences laboratories achieve Green Lab Certification

Sai Life Sciences has achieved Green Lab Certification for two PR&D laboratories and two Medicinal Chemistry laboratories under the My Green Lab (MGL) framework, with a compliance score of over 98%.The certification reflects the company’s systematic efforts to integrate sustainability into daily laboratory operations, with measurable reductions in energy consumption, water usage, waste generation, and […]
Read more

2025.12.19

Sai Life Sciences Releases Sustainability Report 2025

Sai Life Sciences Limited (BSE: 544306 | NSE: SAILIFE), one of India’s fastest-growing Contract Research, Development, and Manufacturing Organizations (CRDMO), today announced the release of its Sustainability Report for 2024–25. Aligned with the Global Reporting Initiative (GRI) Universal Standards 2021 and the Sustainability Accounting Standards Board (SASB) standards, this sixth edition is presented under the […]
Read more

2025.12.15

Pushing Boundaries in Organic Chemistry: IISc Prof. Santanu Mukherjee at Sai Life Sciences

As part of Sai Life Sciences’ ongoing initiative to foster meaningful scientific engagement through interactions with distinguished researchers, Prof. Santanu Mukherjee, Professor in the Department of Organic Chemistry at IISc Bangalore, visited our Integrated R&D campus for a full-day programme of knowledge exchange. He delivered an insightful masterclass on his group’s work in enantioselective desymmetrization—a […]
Read more

2025.11.27

India is evolving from being a tactical supplier to a strategic partner to global pharma

Krishna Kanumuri, MD & CEO of Sai Life Sciences, was recently interviewed by Pharmaceutical Executive for its feature on next-generation CDMOs. In the interview, he shares insights on how Indian CDMOs are evolving from tactical suppliers to strategic partners, the shifting global supply-chain landscape, and how Sai Life Sciences is preparing for the opportunities and […]
Read more